Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’
Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
https://spectator.org/its-time-to-regenerate-the-spirit/?utm_source=rss&utm_medium=rss&utm_campaign=its-time-to-regenerate-the-spirit...
https://spectator.org/blue-states-are-moving-legislation-forward-to-restrict-how-much-you-can-drive/?utm_source=rss&utm_medium=rss&utm_campaign=blue-states-are-moving-legislation-forward-to-restrict-h...
